Mycobacterium bovis endophthalmitis from BCG immunotherapy for bladder cancer

Ocular Immunology and Inflammation

Volumn 16, Issue 3, 2008, Pages 95-97

  Gerbrandy, S J F ^a   Schreuders, L C ^b   De Smet, M D ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Bladder; Cancer; Immunotherapy

Indexed keywords

BCG VACCINE; ETHAMBUTOL; ISONIAZID; PREDNISOLONE; RIFAMPICIN;

AGED; ANAMNESIS; ARTICLE; BCG VACCINATION; BLADDER CANCER; CASE REPORT; CELLULAR IMMUNITY; ENDOPHTHALMITIS; EYE SURGERY; HOSPITAL ADMISSION; HUMAN; IMMUNOTHERAPY; KIDNEY FAILURE; MALE; MYCOBACTERIUM BOVIS; RHEUMATIC POLYMYALGIA; T LYMPHOCYTE; TRANSURETHRAL RESECTION; VISUAL ACUITY;

AGED, 80 AND OVER; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; GLUCOCORTICOIDS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOTHERAPY; MALE; MYCOBACTERIUM BOVIS; POLYMYALGIA RHEUMATICA; PREDNISOLONE; TUBERCULOSIS, OCULAR; URINARY BLADDER NEOPLASMS;

EID: 45749156784     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940802056273     Document Type: Article

References (13)

1. Lamm DL. Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer. Clin Infect Dis. 2000;31(Suppl 3):S86-S90.
2. Lamm DL, van der Meijden PM, Morales A et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol. 1992;147(3):596-600.
3. Paterson DL, Patel A. Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment. Aust N Z J Surg. 1998;68(5):340-344.
4. Dehaven JI, Traynellis C, Riggs DR, Ting E, Lamm DL. Antibiotic and steroid therapy of massive systemic bacillus Calmette-Guerin toxicity. J Urol. 1992;147(3):738-742.
5. Damato FJ. B.C.G. vaccine and phlyctenular kerato-conjunctivitis. Br J Ophthalmol. 1951;35(7):416-418.
6. Frandsen E. Eye lesions suspect of tuberculosis in BCG-vaccinated patients. Acta Ophthalmol (Copenh). 1953;31(4):305-319.
7. Wertheim M, Astbury N. Bilateral uveitis after intravesical BCG immunotherapy for bladder carcinoma. Br J Ophthalmol. 2002;86(6):706.
8. Lester H, Erdey RA, Fastenberg DM, Schwartz PL, Rosenhaus JB. Bacillus Calmette-Guerin (BCG) endophthalmitis. Retina 1988;8(3):182-184.
9. Han DP, Simons KB, Tarkanian CN, Moretti ST. Endophthalmitis from Mycobacterium bovis-bacille Calmette-Guerin after intravesicular bacille Calmette-Guerin injections for bladder carcinoma. Am J Ophthalmol 1999;128(5):648-650.
10. Cambier J. Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling. Immunol Rev. 2005;205:5-6.
11. Vesosky B, Turner J. The influence of age on immunity to infection with Mycobacterium tuberculosis. Immunol Rev. 2005;205:229-243.
12. Moshfeghi DM, Dodds EM, Couto CA et al. Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 2004;111(4):716-725.
13. Dalessandro L, Bottaro E. Reactivation of CMV retinitis after treatment with subtenon corticosteroids for immune recovery uveitis in a patient with AIDS. Scand J Infect Dis. 2002;34(10):780-782.